COX-2 expression in normal and malignant or metastatic tissues from HNSCC patients was compared using published datasets, and results demonstrated that COX-2 expression was higher in malignant tissues than in normal tissues from HNSCC patients (Supplemental Figure S1B). The gene discussed is PTGS2; the disease is head and neck squamous cell carcinoma.